ReNeuron (LON: RENE)

ReNeuron (LON: RENE)

Postby helios » Wed Dec 30, 2009 1:50 pm

:arrow: one of the companies i am reading up ...


Dec. 23 (Bloomberg) -- A neurosurgeon at Southern General Hospital in Glasgow, Scotland, plans to drill a hole in a patient’s skull, insert a needle and inject 2 million stem cells from ReNeuron Group Plc into his brain early next year.

The patient is the first of 12 men disabled by strokes who expect to receive from 2 million to 20 million stem cells grown from the brain of an aborted 12-week-old fetus. The men would be studied for two years to see if the cells help the brain repair damage, without causing further harm.

ReNeuron won U.K. government approval in January to test its ReN001 stem-cell line after three failures to get permission from U.S. regulators. Preliminary analysis of the study next year will determine whether Guildford, England-based ReNeuron can continue developing the treatment and may also determine the viability of the company, whose market value is 19.9 million pounds ($32 million).

Source: http://www.bloomberg.com/apps/news?pid= ... 7QxzgHwETQ
[Finance disclaimer: The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought regarding investing of any stocks/ funds and/or whatsoever. The author has no vested interest in the mentioned stock at the time of writing.
helios
Permanent Loafer
 
Posts: 3608
Joined: Wed May 07, 2008 8:30 am

Return to L to R

Who is online

Users browsing this forum: No registered users and 1 guest

cron